Angioslide Ltd.

by Mary Thompson The market for interventional devices designed to treat peripheral artery disease (PAD) has long taken a backseat to the more high-profile interventional cardiology arena. However, wi

While the debate continues about whether embolic protection devices are really necessary, the space continues to generate interest from investors, start-ups and large companies looking for new technol

One of the most successful centers of medical device innovation, Israel is wrestling with that success and adopting new models to build on it. by David Cassak Over the past decade or so, Israel has cl